Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

GeoSolar Technologies Inc. Is ‘One to Watch’

GeoSolar Technologies is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources The company’s technology has been installed in multiple test homes in Colorado and achieved exceptional results The GeoSolarPlus system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system The […]

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Enhances Bioavailability of Orally Administered APIs

Lexaria is a global innovator in drug delivery platforms The company has developed the patented DehydraTECH(TM) technology that significantly improves the bioavailability of orally administered pharmaceuticals and therapeutics Bioavailability is the fraction of a drug that reaches the site of action or systemic circulation While drugs delivered intravenously are 100% bioavailable, drugs that have any […]

Odyssey Health, Inc.’s (ODYY) Sports Advisory Board Enhancing Public Awareness and Understanding of Traumatic Brain Injuries

Odyssey’s Sports Advisory Board (“SAB”) was formed in 2021 to enhance public awareness of traumatic brain injuries and concussion The board’s members – Abby Wambach, Kurt Warner, and Brett Favre – have had storied careers in their respective sports and have expressed hope that scientists will examine their brains after their death to advance their […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expands Patient Eligibility for Brain Cancer Drug Trial, Receives Approval from U.S. FDA for Protocol Amendment

Novel brain cancer drug developer CNS Pharmaceuticals, Inc. has received approval from the U.S. FDA for a Protocol Amendment that expands patient eligibility for participation in its potentially pivotal Phase 2 clinical trial for a novel drug candidate that targets the nearly 100 percent fatal cancer glioblastoma (“GBM”) CNS is developing the drug candidate Berubicin […]

Flora Growth Corp.’s (NASDAQ: FLGC) Shareholders Vote in Favor of All Proposals Submitted for Approval; Elect Brandon Konigsberg to Board of Directors

Shareholders approve all proposals submitted at this year’s annual shareholders’ meeting, including board members Among the seven members of the Board of Directors elected, six were incumbents, making Brandon Konigsberg the newest addition to the Board Mr. Konigsberg will lend his years of experience, having held key leadership positions in various organizations in the country […]

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Expands Lightning Network Reach with 17 International Nodes Routing Over 72 BTC and 36,000 Transactions

LQwD currently has Lightning Network nodes in several countries, including Canada, France, Italy, Indonesia, Japan, England, Bahrain, South Africa, South Korea, Sweden, Singapore, Brazil, Germany, India, Ireland, Hong Kong, and the United States Arcane Research reported that since its launch three years ago, the Lightning Network has grown to a capacity of almost 3,000 BTC […]

Freight Technologies Inc. (NASDAQ: FRGT) Is ‘One to Watch’

Fr8Tech aims to revolutionize cross-border shipping by providing shippers flexibility, visibility and simplicity Through Fr8app, the company reduces human touch points and expedites load booking times Fr8Tech seeks to lessen the carbon footprint of the logistics industry by minimizing empty miles for transportation firms and reducing overall paper consumption The company’s established foothold in Mexico, […]

DGE’s Medical Publication & Scientific Communications Summit Confronts the Biggest Challenges in Patient Relationships and Medical Misinformation

The Medical Publication and Scientific Communications Summit explores how communications and information professionals can convey crucial information to HCP decision-makers and non-expert audiences in a transparent, credible, and unbiased manner. The summit is organized at a crucial time when there is mistrust and misinformation in the medical industry. Industry thought leaders will offer their valuable […]

 

From Our Blog

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Starts Confirmation Drilling Program in Val-d’Or Gold Belt to Validate Historical Results at Swanson

November 18, 2025

This article has been disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may include paid advertising. LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0), Canadian gold exploration and development company is advancing the district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt while in parallel is progressing toward […]

Rotate your device 90° to view site.